Physicians Go Digital Across the Globe - Webinar May 19

Manhattan ResearchPhysician consumption of digital information sources for professional purposes is accelerating across the U.S., Europe and Asia, according to pharmaceutical and healthcare market research company Manhattan Research. Doctors across the globe are increasing their reliance on the Internet to access journals, medical references, news, conferences, and continuing medical education, diminishing the relevance of the offline versions of these resources each year. Additionally, physicians in these markets visit online resources at multiple points a day through both computers and mobile devices to support clinical decisions, make recommendations to patients, and stay up-to-date with the latest advances in the medical field.

This outlook of the global physician market comes from Manhattan Research's recently released suite of Taking the Pulse® studies. The suite is comprised of three studies that provide insight on the latest technology adoption and usage trends among physicians in the U.S., Europe and Asia, respectively.

"Judging by the rapid increase in physician technology adoption we've seen over the past five years, we expect to see the Internet overtake its traditional counterparts as the go-to source of professional information for physicians in the near future," said Mark Bard, President of Manhattan Research. "For pharma, biotech and device companies targeting physicians in the U.S., Europe and Asia, it’s important for their brands to leverage digital channels in promotional efforts to reach the large majority of physicians using the Internet to aid product and treatment decisions throughout the day."

On May 19, 2009 at 11am ET, President Mark Bard will host a webinar highlighting some of the key global physician channel shifts and will give a holistic view of how digital is evolving physician marketing and CRM strategies across the world.

Questions to be answered in the webinar include:

  • How does physician technology adoption and integration differ in the U.S., Europe and Asia - and can certain similarities across regions help companies to market more efficiently?
  • Discover areas of unmet demand for pharmaceutical promotion - For which online channels do physician demand exceed supply, revealing opportunities for innovative companies to satisfy these unmet needs?
  • It's been said that the sales rep is dead - but is this really true across all industry markets? How is the role of the sales rep evolving in the U.S., Europe and Asia, and how can companies leverage emerging technologies for more efficient sales strategies on a global level?
The Digital Doctor Goes Global: Using Emerging Technologies to Improve Physician Marketing & CRM in the U.S., Europe and Asia

Tuesday, May 19, 2009 11:00 AM - 11:40 AM ET

Sign up here: https://www2.gotomeeting.com/register/821006419

About Taking the Pulse® U.S., Europe and Asia
Taking the Pulse® U.S., Europe and Asia are three separate market research and strategic advisory service focused on which technologies physicians have adopted, how they are currently using them, and how they plan to use them in the future. This year's Taking the Pulse® was conducted in Q1 2009 among a nationally representative sample of 1,900 practicing U.S. physicians, while the Europe and Asia versions were conducted in Q4 2008 and both include a sample of 1,000 practicing physicians. Topics include the Internet, Web 2.0 technologies, email communication, PDAs/smartphones, search engines, detailing/tech-enabled sales reps, patient interaction/education, and digital health infrastructure.

In addition to the data, clients receive strategic deliverables including research reports, client briefings, and access to the Manhattan Research analyst team to answer specific questions.

For additional product and subscription information, please visit http://www.manhattanresearch.com/products/Physician.aspx.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Lilly will supply an additional 150,000 doses of b…

Eli Lilly and Company (NYSE: LLY) announced a modified purchase agreement with the U.S. government to supply an additional 150,000 doses of bebtelovimab for approximately...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

The fourth COVID-19 vaccine reduces the risk of de…

A new study by Tel Aviv University and Ben Gurion University of the Negev, in collaboration with the Israeli Ministry of Health, has found that the fourth COVID-19 vaccin...

Vaccine protection against COVID-19 short-lived, b…

Since COVID-19 vaccines first became available to protect against infection and severe illness, there has been much uncertainty about how long the protection lasts, and w...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Research shows investigational drug fosters nerve …

Scientists from the University of Birmingham have shown that a brain-penetrating candidate drug currently in development as a cancer therapy can foster regeneration of da...

NIH launches clinical trial of mRNA Nipah virus va…

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an inv...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...